. Author manuscript; available in PMC: 2021 Jul 12.

Published in final edited form as: J Pathol. 2019 Dec 3;250(2):205–216. doi: 10.1002/path.5361

Table 2.

Characteristics of the 63 patients analysed for survival

Age, years
Mean	61.0±10.6
Median (range)	61 (27–87)
Sex, No. (%)
Male	47 (75)
Female	16 (25)
Histology, No. (%)
Epithelial	53 (84)
Biphasic	7 (11)
Sarcomatoid	3 (5)
Tumour positive for membranous CD70, No. (%)	20 (32)
CD27⁺ TILs (/HPF)	6 (3–15)
CD3⁺ TILs (/HPF)	11 (3–29.75)
CD4⁺ TILs (/HPF)	28 (9–61.75)
CD8⁺ TILs (/HPF)	16 (7–34)
CD56⁺ TILs (/HPF)	1 (0–6)
PDCD1⁺ TILs (/HPF)	1 (0–3)
FOXP3⁺ TILs (/HPF)	6 (2–19)

Data for TILs are shown as median (25–75 percentiles). TILs, tumour-infiltrating lymphocytes; HPF, high-power field (×400).